A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting Conditions
NCT00864760
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Gabapentin 800 mg tablets, single dose (1 tablet)
DRUG:
NEURONTIN® 400 mg capsules, single dose (2 capsules)
Sponsor
Actavis Inc.